Fortive Investing Cash Flow increased by 52.5% to -$26.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.9%, from -$26.20M to -$26.70M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -52.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$6.50M | -$1.17B | -$1.43B | -$17.90M | -$20.80M | -$29.60M | -$34.20M | -$24.80M | -$16.10M | -$83.30M | -$71.20M | -$1.74B | -$44.80M | -$17.60M | $0.00 | -$26.20M | -$24.60M | -$28.40M | -$56.20M | -$26.70M |
| QoQ Change | — | <-999% | -22.6% | +98.8% | -16.2% | -42.3% | -15.5% | +27.5% | +35.1% | -417.4% | +14.5% | <-999% | +97.4% | +60.7% | +100.0% | — | +6.1% | -15.4% | -97.9% | +52.5% |
| YoY Change | — | — | — | — | -220.0% | +97.5% | +97.6% | -38.5% | +22.6% | -181.4% | -108.2% | <-999% | -178.3% | +78.9% | +100.0% | +98.5% | +45.1% | -61.4% | — | -1.9% |